SynAct Pharma: New Indication Provides Diversification
27 juni, 07:10
27 juni, 07:10
Redeye updates its base case of Synact following the directed share issue and new programme in polymyalgia rheumatica, which broadens resomelagon’s potential and diversifies its clinical development risk.
27 juni, 07:10
Redeye updates its base case of Synact following the directed share issue and new programme in polymyalgia rheumatica, which broadens resomelagon’s potential and diversifies its clinical development risk.
Rapportperioden
Plejd
Inflationen
Rapportperioden
Plejd
Inflationen
1 DAG %
Senast
sbab
Idag, 10:15
SBAB:s krympande intäkter
OMX Stockholm 30
1 DAG %
Senast
2 527,11